Stockreport

LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

LAVA Therapeutics N.V. - Ordinary Shares  (LVTX) 
PDF UTRECHT, The Netherlands and PHILADELPHIA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA”), a clinical-stage immuno-oncology company f [Read more]